Skip to content

US · CHE · MEDICAL - CARE FACILITIES

Chemed Corporation (CHE) intrinsic value and stock valuation

$548.59as of 2026-11-21 · Mkt cap 7.14B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Chemed Corporation DCF and intrinsic value

InvestorsCraft values CHE with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from CHE’s statements →

Chemed Corporation Graham Number

Graham Number: $167.91d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Cincinnati, OH 45202-4726 chemed.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$2.53B+4% 5y CAGRd
20112025
Net income
$265.2M-3.7% 5y CAGRd
20112025
Free cash flow
$325.5M-5.4% 5y CAGRd
20112025
Total equity
$979.4M+1.7% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$2.53B$2.43B$2.26B$2.13B$2.14B
Operating income$338.3M$366.5M$340.6M$343.5M$343M
Net income$265.2M$302M$272.5M$249.6M$268.6M
EPSd$18.4M$19.9M$17.9M$16.5M$16.8M
Operating cash flow$388.3M$417.5M$330.3M$309.9M$308.6M
Capital expenditure-$-62.8M-$-49.53M-$-56.85M-$-57.33M-$-58.67M
Free cash flow$325.5M$368M$273.4M$252.6M$249.9M
Total assets$1.64B$1.67B$1.67B$1.44B$1.34B
Total debt$154.8M$140.8M$155.1M$247M$323.5M
Net debt$80.2M-$-37.51M-$-108.85M$172.9M$290.7M
Total equity$979.4M$1.12B$1.11B$798.7M$623.3M
Cash and short-term investments$74.5M$178.4M$264M$74.1M$32.9M
Income statement
20252024202320222021
Revenue$2.53B$2.43B$2.26B$2.13B$2.14B
Cost of revenue$1.77B$1.58B$1.47B$1.37B$1.37B
Gross profit$758.3M$854.4M$798.8M$765.1M$769.8M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$417.2M$424.4M$395.1M$358.7M$366.7M
Other expenses$0.00$63.5M$63.1M$62.9M$60M
Operating expenses$417.2M$487.9M$458.3M$421.6M$426.8M
Cost and expenses$2.19B$2.06B$1.92B$1.79B$1.8B
Interest income$8.74M$14.6M$6.27M$350K$380K
Interest expense$1.75M$1.78M$3.11M$4.58M$1.87M
Depreciation and amortization$64.8M$63.1M$60.9M$59.2M$59.1M
Ebitda$422.4M$464.3M$414.3M$393.4M$411.2M
Operating income$338.3M$366.5M$340.6M$343.5M$343M
Total other income/expenses, net$17.5M$33M$9.8M-$-13.82M$7.28M
Income before tax$355.8M$399.5M$350.4M$329.7M$350.3M
Income tax expense$90.5M$97.5M$77.9M$80.1M$81.8M
Net income$265.2M$302M$272.5M$249.6M$268.6M
Weighted average shares outstanding$14.4M$15M$15.1M$14.9M$15.7M
Weighted average diluted shares outstanding$14.4M$15.2M$15.2M$15.1M$15.9M
Balance sheet
20252024202320222021
Cash and short-term investments$74.5M$178.4M$264M$74.1M$32.9M
Net receivables$182.6M$171.2M$181.5M$139.4M$137.2M
Inventory$7.54M$8.19M$12M$10.3M$10.1M
Total current assets$302.6M$394.8M$500.8M$272.6M$230.3M
Property, plant and equipment, net$336.8M$328.2M$330.2M$335.4M$318.7M
Goodwill and intangible assets$749.8M$759M$675.3M$681M$686.7M
Long-term investments$140.4M$0.00$0.00$0.00$98.9M
Total non-current assets$1.34B$1.27B$1.17B$1.17B$1.11B
Total assets$1.64B$1.67B$1.67B$1.44B$1.34B
Accounts payable$53.5M$44.2M$64M$41.9M$73M
Short-term debt$51.9M$42.3M$54.3M$44M$37.9M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$287.1M$285.7M$312.1M$297.2M$302.4M
Long-term debt$102.9M$98.5M$100.8M$203M$285.6M
Deferred revenue, non-current$136.1M$0.00$0.00$0.00$0.00
Total non-current liabilities$373.5M$263.9M$248.2M$346.1M$417.1M
Capital lease obligations$102.9M$140.8M$139.4M$149.5M$138.5M
Total liabilities$660.6M$549.6M$560.2M$643.3M$719.5M
Common stock$37.6M$37.4M$37.2M$36.8M$36.5M
Retained earnings$2.96B$2.72B$2.45B$2.2B$1.97B
Accumulated other comprehensive income (loss)$2.35M$0.00$0.00$0.00$0.00
Total equity$979.4M$1.12B$1.11B$798.7M$623.3M
Total investments$140.4M$0.00$0.00$0.00$98.9M
Total debt$154.8M$140.8M$155.1M$247M$323.5M
Net debt$80.2M-$-37.51M-$-108.85M$172.9M$290.7M
Cash flow statement
20252024202320222021
Net income$265.2M$302M$272.5M$249.6M$268.6M
Depreciation and amortization$64.8M$63.1M$60.9M$59.2M$59.1M
Stock-based compensation$4.89M$32M$30.1M$26.3M$22.5M
Change in working capital$23.7M$8.13M-$-39.31M-$-33.49M-$-26.8M
Accounts receivable-$-11.6M$10.7M-$-41.49M-$-2.41M-$-8.43M
Inventory$650K$3.83M-$-1.73M-$-160K-$-3.01M
Accounts payable-$-5.19M-$-9.28M-$-9.35M$15.3M$9.83M
Net cash provided by operating activities$388.3M$417.5M$330.3M$309.9M$308.6M
Investments in property, plant and equipment-$-62.8M-$-49.53M-$-56.85M-$-57.33M-$-58.67M
Acquisitions, net-$-230K-$-97.4M-$-3.99M-$-3.53M$0.00
Net cash used for investing activities-$-59.34M-$-143.91M-$-60.64M-$-59.4M-$-57.76M
Common stock issued$27.2M$0.00$0.00$0.00$0.00
Common stock repurchased-$-431.5M-$-361.39M-$-67.7M-$-114.52M-$-576.04M
Dividends paid-$-31.7M-$-27.09M-$-23.5M-$-22.02M-$-22.02M
Net cash used for financing activities-$-432.77M-$-359.19M-$-79.83M-$-209.25M-$-380.62M
Net change in cash-$-103.83M-$-85.61M$189.8M$41.2M-$-129.78M
Cash at end of period$74.5M$178.4M$264M$74.1M$32.9M
Operating cash flow$388.3M$417.5M$330.3M$309.9M$308.6M
Capital expenditure-$-62.8M-$-49.53M-$-56.85M-$-57.33M-$-58.67M
Free cash flow$325.5M$368M$273.4M$252.6M$249.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Chemed Corporation

        Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

        CEO
        Kevin J. McNamara
        Employees
        15.81K
        Beta
        0.52

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Chemed Corporation (CHE)?

        Chemed Corporation (CHE) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CHE undervalued?

        CHE trades at a price of $548.59 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.